Search Medical Condition
Please enter condition
Please choose location from dropdown

St. Charles, Missouri Clinical Trials

A listing of St. Charles, Missouri clinical trials actively recruiting patient volunteers.

RESULTS

Found (346) clinical trials

Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 7 to 11 Years With Major Depressive Disorder (MDD)

Investigation of the efficacy and safety of a new potential treatment of Major depressive disorder (MDD) in paediatric patients (age 7 to 11 years)

Phase

0.0 miles

Learn More »

Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads

The QP ExCELs study is designed to confirm safety and efficacy of the BIOTRONIK Sentus OTW QP left ventricular leads to satisfy FDA requirements for regulatory approval of the leads in the US. The Sentus OTW QP leads received FDA approval on May 4, 2017. Long-term safety of the BIOTRONIK ...

Phase N/A

0.0 miles

Learn More »

This 52-week study consists of 9 visits to our office and 5 phone call visits. Breathing tests, physical exams, vital signs, ECG's, and blood tests will all be performed throughout the study.

Phase

0.0 miles

Learn More »

QP ExCELs: MultiPole Pacing (MPP) Sub-Study

The objective of this MultiPole Pacing (MPP) sub-study of the QP ExCELs study is to demonstrate that the MPP feature is effective by converting a percentage of cardiac resynchronization therapy (CRT) non-responders to responders. The MPP sub-study is a single-arm, multi-center, prospective trial within the ongoing QP ExCELs study (NCT02290028).

Phase N/A

1.04 miles

Learn More »

Phase

1.04 miles

Learn More »

This study is basically comparing two products that are already on the market for patients with COPD, which includes chronic bronchitis and emphysema. The study lasts for approximately 6 months and compensation is provided for your time and travel.

Phase

1.04 miles

Learn More »

This study is comparing a fixed-dose Triple combination product to a fixed-dose dual combination product. The study is for a 12-week duration. We are also including an option for a 24-hour Holter Monitoring as a sub-study to the main study.

Phase

1.04 miles

Learn More »

Pivotal Study to Assess the Efficacy Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 Inflammation

Approximately 68 weeks including a 4-week screening period, a 52-week treatment period, and 12 weeks of follow-up.

Phase

1.04 miles

Learn More »

A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Subjects With Early Alzheimer's Disease

The name of this trial is MissionAD1. This phase 3 study consists of a Core and Open Label Extension (OLE) Phase in participants with Early Alzheimer's Disease (EAD), and will be conducted to evaluate the efficacy and safety of E2609. The Core is a 24-month treatment, multicenter, double blind, placebo ...

Phase

3.22 miles

Learn More »